@Article{Matusiak2024,
journal="Dermatology Review/Przegląd Dermatologiczny",
issn="0033-2526",
volume="111",
number="1",
year="2024",
title="Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa",
abstract="Hidradenitis suppurativa is a chronic, recurrent, inflammatory skin disease that affects hair follicles, typically developing after puberty. It is characterized by painful, deep-seated inflammatory lesions that appear in anatomical regions where apocrine glands are located, mainly in the axillar, inguinal, and anogenital areas. The pathogenesis of hidradenitis suppurativa is multifactorial, with follicular occlusion representing the initial stage of the disease and subsequently leading to the formation of neutrophilic abscesses and infiltration by various inflammatory cells. The treatment of hidradenitis suppurativa requires a multidisciplinary approach, involving dermatologists and dermatologic surgeons, as well as physicians of other medical specialties. The primary pharmacological treatments for hidradenitis suppurativa involve antibiotics and biologic disease-modifying drugs, which can be used either in monotherapy or in combination with surgical interventions. The following guidelines provide up-to-date information on the management of patients with hidradenitis suppurativa.",
author="Matusiak, Łukasz
and Walecka, Irena
and Reich, Adam
and Bieniek, Andrzej
and Krasowska, Dorota
and Barańska-Rybak, Wioletta
and Bergler-Czop, Beata
and Lesiak, Aleksandra
and Narbutt, Joanna
and Owczarczyk-Saczonek, Agnieszka
and Owczarek, Witold
and Szepietowski, Jacek",
pages="1--19",
doi="10.5114/dr.2024.140820",
url="http://dx.doi.org/10.5114/dr.2024.140820"
}